Edition:
India

People: CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

17.40HKD
18 Oct 2019
Change (% chg)

HK$0.50 (+2.96%)
Prev Close
HK$16.90
Open
HK$16.92
Day's High
HK$17.58
Day's Low
HK$16.84
Volume
33,956,018
Avg. Vol
37,147,098
52-wk High
HK$19.26
52-wk Low
HK$9.90

Cai, Dongchen 

Mr. Cai Dongchen is Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Cai is also the chairman of the Nomination Committee of the Company and a director of certain subsidiaries of the Group. Mr. Cai holds a MBA degree from Nankai University and has extensive technical and management experience in the pharmaceutical industry. Mr. Cai is a substantial shareholder of the Company within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”). Mr. Cai is also a director of True Ally Holdings Limited and Massive Giant Group Limited, both are substantial shareholders of the Company within the meaning of Part XV of the SFO.

Basic Compensation

Total Annual Compensation, HKD 13,362,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 443,000
Fiscal Year Total, HKD 13,805,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dongchen Cai

13,805,000

Cuilong Zhang

4,326,000

Kin Man Chak

5,269,000

Chunlei Li

4,783,000

Hua Lu

4,205,000

Weidong Pan

4,387,000
As Of  31 Dec 2018